CSIMarket
 


Cytosorbents Corporation  (CTSO)
Other Ticker:  
 

Cumulative Cytosorbents's Long Term Debt to Equity for Trailing Twelve Months Period

CTSO's Long Term Debt to Equity for Trailing Twelve Months Period and Long Term Debt, Equity growth


Select the Comparisons : Select the Ratio:

CTSO Long Term Debt to Equity for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth -34.2 % -52.71 % -49.34 % -47.76 % -43.47 %
Y / Y Long Term Debt Growth -49.14 % - - - -
Long Term Debt to Equity for Trailing Twelve Months Period 0.12 0.13 0.08 0.03 0.03
Total Ranking # 397 # 627 # 491 # 286 # 361
Seq. Equity Growth 25.73 % -23.17 % -16.79 % -18.15 % -9.62 %
Seq. Long Term Debt Growth -39.44 % -16.38 % - - -


Long Term Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to long-term debt repayement of -39.44% Cytosorbents decreased Long Term Debt to Equity for Trailing Twelve Months Period in the IV. Quarter to 0.12, below company's average Long Term Debt to Equity for Trailing Twelve Months Period.
Long Term Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 13 other companies have achieved lower Long Term Debt to Equity for Trailing Twelve Months Period than Cytosorbents. While total ranking remained unchanged compare to previous quarter at no. .

What is Long Term Debt to Equity Ratio?
What is CTSO selling?
Long Term Debt to Equity CTSO in the most recent quarter
Long Term Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 14
Sector # 54
S&P 500 # 367


Long Term Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
1.16 0.45 0.02
(Dec 31 2019)   (Jun 30 2021)




Companies with similar average Long Term Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Medical Equipment & Supplies Industry Long Term Debt to Equity for Trailing Twelve Months Period
Plus Therapeutics Inc   0.32 
Pro dex Inc   0.31 
Apyx Medical Corporation  0.31 
Merit Medical Systems Inc  0.31 
Dariohealth Corp   0.29 
Si bone inc   0.27 
Surmodics Inc  0.27 
Envista Holdings Corporation  0.27 
Catheter Precision Inc   0.25 
Beyond Air Inc   0.25 
Paragon 28 Inc   0.23 
Pulmonx Corporation  0.23 
Sight Sciences Inc   0.23 
Procept Biorobotics Corporation  0.22 
Innovage Holding Corp   0.21 
Rxsight Inc   0.20 
Cvrx inc  0.18 
Precision Optics Corporation Inc   0.17 
Avanos Medical Inc   0.17 
Ufp Technologies Inc   0.17 
Irhythm Technologies Inc   0.16 
Lifestance Health Group Inc   0.16 
Tactile Systems Technology Inc   0.14 
Intelligent Bio Solutions Inc   0.12 
Atricure Inc   0.11 
Cytosorbents Corporation  0.11 
Carmell Corporation  0.11 
Encision Inc   0.10 
Edwards Lifesciences Corporation  0.09 
Sanara Medtech Inc   0.09 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com